Clinical Trial Update: Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial update indicates the Phase 1/2 study of PBKR03 in pediatric subjects with Krabbe disease is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Krabbe Disease

Drugs mentioned

• PBKR03

Snippet

Sponsor: Gemma Biotherapeutics | Conditions: Leukodystrophy, Globoid Cell | Phase 1, Phase 2 | Status: SUSPENDED